Atnaujinta: 2024.07.04 16:07 (GMT+3)

Tallinna Farmaatsiatehas: Consolidated balance sheet 31.12.99

2000.01.31, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
BALANCE SHEET

CONSOLIDATED BALANCE SHEET 31.12.99

Consolidated, unaudited, in thousand EEK

Consolidated Parent
ASSETS 31.12.1999 31.12.1998 31.12.1999 31.12.1998

CURRENT ASSETS
Cash and bank 1783 1933 1783 1930

Customer receivables 26306 16282 26306 16282
Other receivables 3688 7571 3688 7366
TOTAL RECEIVABLES 29993 23852 29993 23648

Inventories 13831 20191 13831 20119
Work-in-progress 880 700 880 700
Finished goods 12949 15515 12949 8339
Total goods and inventories 27659 36405 27659 23456

TOTAL CURRENT ASSETS 59434 62189 59434 48767

Tangible assets at residual value 33491 36749 33491 34528
Unrealized capital investments 1319 2648 1319 1638
Total tangible assets 34810 39397 34810 36166

Investments in associated companies 7953 7953
Other shares and units
Intangible assets 3219 4023 3219 4023
Other non-current receivables 472 530 472 527

TOTAL NON-CURRENT ASSETS 38500 51901 38500 49487

TOTAL ASSETS 97934 114090 97934 111396

LIABILITIES AND OWNERS' EQUITY

CURRENT LIABILITIES
Short-term loans 9119 30584 9119 26919
Supplier payables 13186 17154 13186 17154
Salary-related accrued expenses 1119 991 1119 991
Tax liabilities 2020 6925 2020 6847
Customer prepayments 53 9 53 9
Dividends payable 447 447 447 447
Other debt obligations 841 3217 841 4267
TOTAL CURRENT LIABILITIES 26783 59325 26783 56631

Long-term bank loans 59045 48510 59045 48510
Deferred income tax liability
TOTAL NON-CURRENT LIABILITIES 59045 48510 59045 48510

Share capital 2500 37701 12500 37701
Restricted reserves 7665 10185 7665 10185
Retained earnings -13910 -41630 -13910 -41630

Profit for the current year 5851 5851

TOTAL OWNERS' EQUITY 12106 6256 12106 6256
TOTAL LIABILITIES AND OWNERS' EQUITY 97934 114090 97934 111396


Raivo Unt
Financial director
6120201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai